KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Short term Debt (2016 - 2022)

Charles River Laboratories International has reported Short term Debt over the past 14 years, most recently at $2.1 million for Q3 2022.

  • For Q3 2022, Short term Debt fell 8.62% year-over-year to $2.1 million; the TTM value through Sep 2022 reached $2.1 million, down 8.62%, while the annual FY2021 figure was $2.8 million, 94.43% down from the prior year.
  • Short term Debt for Q3 2022 was $2.1 million at Charles River Laboratories International, down from $2.4 million in the prior quarter.
  • Over five years, Short term Debt peaked at $53.7 million in Q2 2020 and troughed at $2.1 million in Q3 2022.
  • A 5-year average of $22.4 million and a median of $31.0 million in 2018 define the central range for Short term Debt.
  • Biggest five-year swings in Short term Debt: skyrocketed 877.21% in 2019 and later plummeted 94.43% in 2021.
  • Year by year, Short term Debt stood at $31.4 million in 2018, then increased by 22.69% to $38.5 million in 2019, then skyrocketed by 30.27% to $50.2 million in 2020, then plummeted by 94.43% to $2.8 million in 2021, then fell by 25.62% to $2.1 million in 2022.
  • Business Quant data shows Short term Debt for CRL at $2.1 million in Q3 2022, $2.4 million in Q2 2022, and $2.6 million in Q1 2022.